Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

Alessandra Lopes, Sara Feola, Sophie Ligot, Manlio Fusciello, Gaëlle Vandermeulen, Véronique Préat, Vincenzo Cerullo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number174
JournalJournal for Immunotherapy of Cancer
Volume7
Issue number1
Number of pages14
ISSN2051-1426
DOIs
Publication statusPublished - 10 Jul 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ACTIVATION
  • CANCER
  • Cancer
  • DNA vaccine
  • EFFICACY
  • IDENTIFICATION
  • INTERLEUKIN-2
  • Melanoma neoantigens
  • NATURAL-KILLER-CELLS
  • NK CELLS
  • Oncolytic adenovirus
  • RECEPTOR
  • RECRUITMENT
  • THERAPY
  • Tumor microenvironment
  • 3122 Cancers

Cite this